Velius is a Global, fully-integrated, research driven, 21st Century, Biopharmaceutical Company. It researches, develops and markets Over the Counter (OTC) and Prescription (Rx) Drugs for percutaneous delivery. It has developed a large pipeline of both OTC and prescription drugs for the Anti-Aging, Dermatology, Scar Repair and Animal Health markets. Its lead OTC product, Scarguard, is for the treatment and management of scars and is sold in most major drugstores in North America. The company is currently working to obtain FDA approval for prescription scar management and psoriasis drugs.